Press Releases

BURLINGTON, ON, Aug. 1,  2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT")&

DUBLIN, Aug. 1, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately.  In this role, Mr. Ciarico will lead commercial strategy and execution for Endo's Generics Phar

MALVERN, Pa., Aug. 1, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that Kanagawa Psychiatric Center is treating the first patient in J

DALLAS, Aug. 1, 2019 /PRNewswire/ -- Riata Capital Group ("Riata") announced that its portfolio company Acuity Eyecare Group ("AEG"), an owner and operator of leading North American eyecare groups and optometry practices, has acquired 11 regional eyecare practices in Texas. These acquisitions are the first for AEG in the

GERMANTOWN, Md., Aug. 1, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of th

BRIDGEWATER, N.J., Aug. 1, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended June 30, 2019 and provided a business update."We are very excited about the conti

LOS ANGELES, Aug. 1, 2019 /PRNewswire/ -- Arosa+LivHOME has agreed to acquire The Cameron Group, a leading provider of care management and home care services in Orlando, Florida, pending regulatory and licensure approval. This will mark Arosa+LivHOME's fifth acquisition since January and entry into its fifth state. 

ROCKVILLE, Md., Aug. 1, 2019 /PRNewswire/ -- Of the two-thirds of Americans who have been prescribed a medication, 50 percent of them don't take their drugs as prescribed1 largely because of the high cost of the drugs and sticker shock at the pharmacy. Twenty to 30 percent of prescriptions are never even filled.2 The impact ripples through hea

SAN FRANCISCO, Aug. 1, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) and Bristol-Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for investigational agent bempegaldesleukin (NKTR-214) in combination with Bristol-Myers Squibb's Opdivo® (nivolumab)

Dermatology.com Supports Lower, Predictable Pricing for Many of Bausch Health's Prescription Dermatology Products at Walgreens 9,500 Retail Pharmacies DEERFIELD, Ill. and LAVAL, Quebec, Aug. 1, 2019 /PRNewswire/ -- Walgreens and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced a modification